glp 1 semaglutida GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations GLP-1s | AgelessRx
Description
Numerous studies have demonstrated that exogenous administration of SCFAs, particularly propionate and butyrate, is beneficial in rodent models of diabetes-like phenotypes [116,117,118]
The 60.3% recurrence rate after stopping suggests ongoing treatment is needed, but long-term safety data for this specific population does not exist
A friend or a coach can boost accountability
This makes it easier to gain weight and harder to lose it
(F&B)
